Drugs / Reduning
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04183725 | Dec 2019 → Jun 2021 | — | China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01145664 | May → Aug 2010 | hand, foot and mouth disease | Beijing YouAn Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reduning | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01145664 ↗ |
| Known as | RDN | “Reduning injection (RDN), a small but fine Chinese herbal formula, has antipyretic, antiviral, anti-inflammatory effects.” PMID 37474974 ↗ Jul 2023 |
| Modality | Traditional medicine (herbal / TCM) | “Chinese medicine (CM)” PMID 27392481 ↗ Jul 2016 |
| Route | Intravenous | “iv drip” NCT04183725 ↗ |